DrugPatentWatch Database Preview
Tolmar Company Profile
What is the competitive landscape for TOLMAR, and when can generic versions of TOLMAR drugs launch?
TOLMAR has twenty-four approved drugs.
There are five US patents protecting TOLMAR drugs.
There are sixty-eight patent family members on TOLMAR drugs in twenty-six countries and fifteen supplementary protection certificates in eight countries.
Summary for Tolmar
| International Patents: | 68 |
| US Patents: | 5 |
| Tradenames: | 16 |
| Ingredients: | 16 |
| NDAs: | 24 |
| Patent Litigation for Tolmar: | See patent lawsuits for Tolmar |
Drugs and US Patents for Tolmar
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolmar | CLOBETASOL PROPIONATE | clobetasol propionate | SOLUTION;TOPICAL | 076977-001 | Aug 5, 2005 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Tolmar | ADAPALENE AND BENZOYL PEROXIDE | adapalene; benzoyl peroxide | GEL;TOPICAL | 206164-001 | May 23, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | RX | Yes | Yes | 8,840,916 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Tolmar
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | RE37950 | Start Trial |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021488-001 | Feb 13, 2003 | 6,773,714 | Start Trial |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | 5,324,519 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Tolmar Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 1331200 | Start Trial |
| Iceland | 6794 | Start Trial |
| Denmark | 1322286 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Tolmar Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1458369 | 08C0024 | France | Start Trial | PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218 |
| 0809498 | SPC/GB10/012 | United Kingdom | Start Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| 0526708 | C300097 | Netherlands | Start Trial | PRODUCT NAME: BOSENTAN, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN HYDRAAT OF IN DE VORM VAN EEN ESTER VAN DE HYDROXYLGROEP VAN DE 2-HYDROXYETHOXY REST MET EEN ZUUR MET DE FORMULE R5-OH, WAARIN R5 EEN C1-7-ALKANOYL, BENZOYL, OF HETEROCYCLYCARBONYL VOORSTELT; NATL. REGISTRATION NO/DATE: U/1/02/220/001 - 005 20020515; FIRST REGISTRATION: CH IKS 58841 01 - 02 20020228 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
